IN BRIEF: Oncimmune Signs Autoantibody Profiling Programme Agreement
IN BRIEF: Oncimmune Signs Autoantibody Profiling Programme Agreement
Read moreMon, 01st Oct 2018 12:47
IN BRIEF: Oncimmune Signs Autoantibody Profiling Programme Agreement
Read more(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an autoantibody profiling collaboration with an unnamed "leading global biopharmaceutical company", it announced on Wednesday, which it said had "extensive experience" in developing novel immune checkpoint inhibitors (CPIs).
Read moreIN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche
Read more(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Monday that Roche has exercised its option to increase the scope and value of the cornerstone contract, initially announced on 28 May.
Read moreIN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil
Read moreUK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares
Read moreUK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service
Read more(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that it expects to report further strong top-line growth in its current trading year.
Read moreOncimmune Inks Further Roche Contract Focused On Immunotherapy Trials
Read moreOncimmune Signs Drug Development Deal With US Biopharmaceutical Firm
Read more(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an antigen-targeting collaboration, it announced on Tuesday, to support drug development with a "leading", unnamed United States biopharmaceutical company, which is developing novel therapies based on the human immune response.
Read moreUK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000
Read moreUK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO
Read moreDIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares
Read moreUK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review
Read more